CURRICULUM VITAE
Dr. Michael Sprintz, DO, DFASAM
PROFILE
Dr. Michael Sprintz is a national expert on addiction and chronic pain. A passionate and engaging public speaker, software entrepreneur, and author, Dr. Sprintz trained at the prestigious Johns Hopkins Hospital and MD Anderson Cancer Center and is triple board-certified in Addiction Medicine, Pain Medicine, and Anesthesiology. He serves on the FDA’s Analgesic and Anesthetic Drug Products Advisory Committee and is the founder of Cellarian, Inc., which develops innovative software that helps healthcare providers identify and treat patients at-risk for substance use disorders. Most importantly, Dr. Sprintz is personally in recovery from opioid and alcohol addiction for over 21 years, which add up to a rare and uniquely insightful perspective.
Subject Matter Expert on Chronic Pain and Addiction, Clinical Healthcare IT
Licensed Physician in the State of Texas
Board Certification | Addiction Medicine, American Board of Preventative Medicine, 2018
Board Certification | Pain Medicine, American Board of Anesthesiology, 2012
Board Certification | Anesthesiology, American Board of Anesthesiology, 2008, Recert 2018
Board Certification | Addiction Medicine, American Board of Addiction Medicine, 2009
Distinguished Fellow | American Society of Addiction Medicine, 2018
Medical Review Officer | Medical Review Officer Certification Council, 2008, Recert 2014
Certification | DEA/DATA 2000 Buprenorphine/Suboxone Certification, 2008
EDUCATION & TRAINING
Fellow, Division of Pain Medicine | MD Anderson Cancer Center, Houston, TX. 2011-2012
Resident, Anesthesiology (Allopathic) (CA-2, CA-3) | University of South Florida College of Medicine, Tampa, FL. 2005-2007
Resident, Anesthesiology/ Critical Care Medicine (CA-1, CA-2) | Johns Hopkins Hospital, Baltimore, MD. 1998-2000
Researcher, Nanomedicine | Universita degli studi Magna Graecia di Catanzaro, Catanzaro Italy. 2004-2005
Post-Doctoral Researcher | Biomedical Nanotechnology, The Ohio State University, Columbus, OH. 2002-2004
Intern, Family Practice (Osteopathic) | Advocate-Christ Hospital, Hometown, IL. 1997-1998
Doctor of Osteopathic Medicine | Chicago College of Osteopathic Medicine of Midwestern U., Downers Grove, IL. 1993-1997
Bachelor of Science | Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, WI. 1989-1993
PROFESSIONAL APPOINTMENTS
Founder, Sprintz Center for Pain & Sprintz Center for Recovery | A best practice model for delivering comprehensive and integrated outpatient care for patients with chronic pain and/or substance use disorders. 2012-2023
Anesthesiologist, locums | Providing safe, outpatient anesthetic care for patients. Houston, TX 2012-2023
Founder and CEO, Cellarian, Inc. | Cellarian delivers win-win software solutions that improve patient care and revenue cycle management with broad data resources, AI-driven analytics and leading-edge automation of prior auth and medical necessity documentation. 2012-Present
Consultant, MPS Consulting and Media | Advise companies, government, healthcare systems and providers on development of effective clinical and business strategies to address the chronic pain and substance abuse epidemics. 2014-Present
Public Speaker, MPS Consulting and Media | Experienced and charismatic speaker with 20+ years in personal recovery and professional expertise, combines with humor and authenticity to create an entertaining information powerhouse that inspires audiences. 2014-Present
PREVIOUS APPOINTMENTS
Attending Anesthesiologist, Division of Regional Anesthesia | Ochsner Health System, New Orleans, LA. 2007-2011
Medical Director, Pain and Recovery Inpatient Program | Memorial Hermann Prevention and Recovery Center (PaRC), Houston, TX. 2013-2014
Research Scientist, Department of Nanomedicine | Methodist Hospital Research Institute, Houston, TX. 2011-2012
PUBLIC SERVICE
Food and Drug Administration | Voting Member, Anesthetic and Analgesic Drug Products Advisory Committee. 2019-2023
Texas Medical Association Committee on Behavioral Health | 2023-Present
Texas Pain Society | Chair and Speaker | TPS Annual Meeting Addiction Medicine Workshop. 2020-Present
2022 Pain Summit Consortium | Member, ASAM Representative; A consortium of 15 Professional Medical Societies to provide guidance on surgical pain management in patients with chronic pain, preexisting opioid use or substance use disorder. 2022
American Society of Regional Anesthesia and Pain Medicine/ American Society of Anesthesiologists | Member & ASRA/ASA Substance Use Disorder Multi-Specialty Working Group. 2020-Present
Food and Drug Administration | Consultant, Anesthetic and Analgesic Drug Products Advisory Committee. 2012-2017
The Joint Commission, Technical Advisory Panel | Chronic Non-Cancer Pain Management in Non-Hospital Settings. 2018
The Joint Commission, Standards Review Panel | Hospital Pain Management. 2017
The Joint Commission, Standards Review Panel | Pain Assessment and Management in Behavioral Health Care. 2018
Texas Society of Addiction Medicine | Past-President 2012-2014
National Alliance for Model State Drug Laws (NAMSDL) | Prescription Drug Abuse, Addiction, and Diversion Working Group. 2012-2013
TENDERED EXPERT WITNESS
Defense: Addiction Medicine; Anesthesiology, 2011
Plaintiff: Addiction Medicine; Pain Medicine, 2015
SELECTED PROFESSIONAL PRESENTATIONS
“Healthy Conversations: How To Engage With Your Patient About Substance Use Disorders.” Texas Medical Association On-Demand Webinar Series. December 2023
“Management of Chronic Pain Patients with Substance Use Disorders.” Texas Medical Association On-Demand Webinar Series. December 2023
“Shades Of Gray: How To Identify Patients At-Risk For Substance Use Disorders.” Texas Medical Association On-Demand Webinar Series. December 2023
“Applying Best Practices in Pain Management: Delivering Holistic Patient-Centered Care to Minimize Health Disparities and Adverse Opioid Outcomes.” Clinical Care Options Opioid REMS Education Initiative. Costa Mesa, CA. December 2023
“Applying Best Practices in Pain Management: Delivering Holistic Patient-Centered Care to Minimize Health Disparities and Adverse Opioid Outcomes.” 9th Annual Psychopharmacology Update. Orlando, FL. December 2023
“Pain and Substance Use Disorders: Protecting Patients, Protecting Providers.” UT Health Coastal Bend Enduring CME Lecture. Webinar. October 2023
“Facing The Pain: What Addiction Providers Really Need To Know About Treating SUD Patients With Pain.” NAADAC 2023 Annual Conference; Denver, CO. October 2023
“AI, Analytics, And Automation In Healthcare: Get On Board Or Get Run Over.” Texas Pain Society Annual Meeting. Bastrop, TX. October 2023
“Impactful Communication: Making the Most of Your 10.7 Minutes.” Texas Pain Society Annual Meeting. Bastrop, TX. October 2023
“How to Safely Taper Opioids: Options, Protocols and Avoiding Landmines.” Texas Pain Society Annual Meeting. Bastrop, TX. October 2023
“How to Safely Taper Opioids: Options, Protocols and Avoiding Landmines.” Texas Pain Society Annual Meeting. Bastrop, TX. October 2023
“Addiction in Chronic Pain Patients-How to Know and What to Do.” Texas Medical Association Annual Meeting TexMed2022. Houston, TX. April 2022.
“Buprenorphine for the Anesthesiologist and Pain Physician.” American Society of Regional Anesthesia and Pain Medicine Virtual Panel with Viscusi E, Kohan L, Portu S, Bently E. August 2020.
“The Talk: How to Effectively Address Tense Situations with Patients Having Co-Morbid Addiction and Pain.” American Society of Addiction Medicine Pain & Addiction Virtual Workshop. April 2020.
“Having 'The Talk': How to Effectively Address Tense Situations with Pain Patients with Known or Suspected Substance Abuse.” Texas Pain Society Annual Meeting. San Antonio, TX. October 2019.
“Medicinal Cannabis: Literature Pros and Cons.” Texas Pain Society Annual Meeting. San Antonio, TX with Finn K. October 2019.
“Water-Wings: Learning to Swim in the Ocean of the Epidemic.” Houston Medication Safety Symposium. Houston, TX. April 2019.
“Balance, Grasshopper: Using Both CAM and “Traditional” Techniques for Comprehensive and Effective Pain Management.” American Society of Addiction Medicine Pain & Addiction Workshop with Dr. Gregory Rudolf. April 2019.
“Using Prescription Drug Monitoring Programs and Other Data to Identify At-Risk Patients and Improve Outcomes.” Texas Society of Addiction Medicine Chronic Pain and Addiction Summit. Austin, TX. February 2019.
“Sherpas in a Minefield: Pain Management and Current Treatment Options in the Shadow of the Opioid Abuse Epidemic.” Texas Pharmacy Association Annual Conference & Expo. The Woodlands, TX. July 2018.
“Bringing This All Together: What a Functional Addiction and Pain Practice Can Look Like.” American Society of Addiction Medicine Pain & Addiction Conference. San Diego, CA with Doctors William Jacobs, Cory Waller, Mark Weiner, Melvin Pohl, Launette Reib, and Terry Rustin. April 2018.
SELECTED PROFESSIONAL PAPERS
Kohan L, Potru S, Barreveld A, Sprintz M, Lane O, Aryal A, Emerick T, Dopp A, Chhay S, Viscusi E. “Buprenorphine Management in the Perioperative Period: Educational Review and Recommendations From a Multi-society Expert Panel.” Reg Anesth Pain Med 2021;0:1–20. doi:10.1136/rapm-2021-103007
Sprintz M, McClain V. “Substance abuse in Healthcare Professionals.” Professional, Ethical, Legal, and Educations in Medicine: A Problem-Based Learning Approach, Edited by K. Lalwani, I. Cohen, E. Choi, J. Kirsch, & B. Robbins. Oxford University Press.
Col N, Hull S, Sprintz M, et al. “Improving patient-provider communication about chronic pain: development and feasibility testing of a shared decision-making tool.” BMC Medical Informatics and Decision Making 20(1):267. October 2020
Hurford B, Sprintz M, et al. “Appropriate Use of Drug Testing in Clinical Addiction Medicine.” Consensus Document of the American Society of Addiction Medicine. Rockville, MD. May 2017.
Sprintz, M et al. “Nanomedicine: Ushering in a new era of pain management.” European Journal of Pain Supplements. November 2011. 5(2): 317-322.
Click for a downloadable copy.
